1. Murray PR, Rosenthal KS MpM. Medical Microbiology 8th ed. Philadelphia, Pennsylvania USA; 2016.
2. Teklu DS, Negeri AA, Legese MH, Bedada TL, Woldemariam HK, Tullu KD. Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia. Antimicrob Resist Infect Control. 2019; 8 (1): 1-12. [
DOI:10.1186/s13756-019-0488-4]
3. Carona Y, Chheanga R, Putheaa N, Sodaa M, Boyerb S, Tarantolac A, Kerléguer A. Beta-lactam resistance among Enterobacteriaceae in Cambodia: The four-year itch. Int J Infect Dis. 2018; 66: 74-79. [
DOI:10.1016/j.ijid.2017.10.025]
4. Paterson DL, Bonomo RA. Extended-Spectrum Beta-lactamases: a clinical update. Clin Microbiol Rev. 2005; 18 (4): 657-86. [
DOI:10.1128/CMR.18.4.657-686.2005]
5. Pitout JDLK. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008; 8(3):159-66. [
DOI:10.1016/S1473-3099(08)70041-0]
6. Ghotasloua R, Sadeghia MR, Akhib MT, Hasanib A, Asgharzadeh M. Prevalence and Antimicrobial Susceptibility Patterns of ESBL, AmpC and Carbapenemase-producing Enterobactericeae Isolated from Hospitalized Patients in Azerbaijan, Iran. Iran. J Pharm Sci. 2018; 17 (Special Issue): 79-88.
7. Spanu T, Luzzaro F, Perilli M, Amicosante G, Toniolo A, Fadda G. The Italian ESBL Study Group. Occurrence of Extended-Spectrum β-Lactamases in Members of the Family Enterobacteriaceae in Italy: Implications for Resistance to β-Lactams and Other Antimicrobial Drugs. Antimicrob Agents Chemother. 2002; 46 (1): 196-202. [
DOI:10.1128/AAC.46.1.196-202.2002]
8. Nwafia IN, Ohanu ME, Ebede SO, Ozumba UC. Molecular detection and antibiotic resistance pattern of extended‑spectrum beta‑lactamase producing Escherichia coli in a Tertiary Hospital in Enugu, Nigeria. Ann Clin Microbiol Antimicrob. 2019; 18 (1): 41. [
DOI:10.1186/s12941-019-0342-9]
9. Clinical and Laboratory Standards Institute. M02: Performance standards for antimicrobial disk susceptibility tests (ISBN: 1-56238-835-5). Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
10. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant, and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012; 18 (3): 268-81. [
DOI:10.1111/j.1469-0691.2011.03570.x]
11. Yousefi Mashouf P, Alijani P, Saidijam M, Alikhani MY, Rashidi H. Study of antibiotic resistance pattern and phenotypic detection of ESBLs in Klebsiella pneumoniae strains isolated from clinical samples and determination of minimum inhibitory concentrations of imipenem and ceftazidim antibiotics. J Hamadan Univ Med Sci. 2014; 20 (4): 295- 302.
12. Adler A, Katz DE, Marchaim D. The continuing plague of extended-spectrum β-lactamase-producing Enterobacteriaceae infections. Infect Dis Clin N Am. 2016; 30 (2): 347-75. [
DOI:10.1016/j.idc.2016.02.003]
13. Khanbeyki S, Ahani Azari A, Danesh A. Prevalence and antibiotic resistance pattern of extended spectrum β-Lactamase- (ESBL-) producing gram negative bacilli isolated from clinical samples of hospitalized patients in a hospital in Gorgan. J Torbat Heydariyeh Univ Med Sci. 2020; 8 (2): 47-56.
14. Didgar F, Sarmadian H, Ghasemikhah R. Antimicrobial resistance pattern of Gram -negative bacilli isolated of Vali-Asr Hospital wards in Arak. Iran South Med J. 2014; 17 (5): 938-47.
15. Bayat Maku ZH, Hassani A, Naqili B, Alipour L. Prevalence of gram-negative bacilli producing broad-spectrum beta-lactamases in clinical samples of hospitalized patients. J Tabriz Univ Med Sci. 2010; 32 (4): 11-5.
16. Mansouri SH, Abbasi S. Prevalence of Multiple Drug Resistant Clinical Isolates of Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in Southeast Iran. Iran J Med Sci. 2010; 35 (2): 101-8.
17. Fendereski A, Ahani Azari A, Dadgar, T. Phenotypic detection of Beta-lactamases among Proteus mirabilis, Enterobacter cloacae, and Citrobacter freundii isolates from urinary samples in Gorgan, Northeast Iran. J Med Microbiol Infect Dis. 2020; 8 (4): 161-5. [
DOI:10.29252/JoMMID.8.4.161]
18. Habibi H., Ahani Azari A., Danesh A. Incidence of beta-Lactamase enzymes among Klebsiella pneumonia isolates causing urinary tract infections in Aliabad, North-East Iran. Infect Epidemiol Microbiol. 2020; 6 (3): 193-200. [
DOI:10.29252/iem.6.3.193]
19. Hosseini SA, Ahani Azari A, Danesh A. Frequency of various types of beta-Lactamase enzymes in Escherichia coli strains isolated from urine samples in Aliabad, North-east of Iran. Avicenna J Clin Microbiol Infect. 2019; 6 (4): 106-10. [
DOI:10.34172/ajcmi.2019.19]
20. Ahani Azari A, Khajeh A, Danesh A. Assessment of antibiotic resistance pattern and frequency of extended spectrum β-lactamases (ESBLs) in gram negative bacteria isolated from urine samples in Bandar-e Torkaman. J Neyshabur Univ Med Sci. 2019; 7 (1): 134-43.
21. Ibrahim M, Abbas M, Al-Shahrai A, Elamin B. Phenotypic Characterization and antibiotic resistance patterns of extended-spectrum β-lactamase- and AmpC β-lactamase-producing gram-negative bacteria in a referral Hospital, Saudi Arabia. Can J Infect Dis Med Microbiol. 2019; 1-9. [
DOI:10.1155/2019/6054694]
22. Mousavian SM, Ahmad Khosravi N, Shoja S. Survey of frequency in extended-spectrum beta-Lactamase producing Enterobacteriaceae and determination of the antibiotic resistant pattern in clinical specimens in teaching hospitals of Ahvaz Jundishapur university of medical sciences. Jundishapur Sci Med J. 2013; 13 (2): 191-9.